Restless legs syndrome in type 2 diabetes mellitus.

Prim Care Diabetes

University of Health Sciences, Dr. Lütfi Kırdar Kartal Training and Research Hospital, Diabetes Center, Department of Internal Medicine, Istanbul, Turkey.

Published: February 2019

AI Article Synopsis

  • The study aimed to determine the prevalence of restless leg syndrome (RLS) in patients with type-2 diabetes mellitus (DM) and identify associated risk factors.
  • Out of 318 diabetes patients observed, the prevalence of RLS was 28.3%, with higher rates in females (33.3%) compared to males (20.6%), and a significant correlation was found between RLS and the duration of diabetes.
  • This research highlights that RLS is more common in type-2 DM patients, particularly among those using insulin, indicating a need for further investigation into these relationships.

Article Abstract

Aims: This study aimed to investigate the prevalence of restless leg syndrome (RLS) in type-2 diabetes mellitus (DM) patients and to determine the risk factors.

Methods: Patients were recruited from the Dr. Lütfi Kırdar Kartal Training and Research Hospital Diabetes Center. Patients between 18-80 years of age and meeting a minimum 5 years diagnosis of type-2 DM were included. All patients were examined by the same neurologist in terms of having RLS. The diagnosis was made according to the updated International Restless Legs Syndrome Study Group consensus criteria. Mimicking conditions such as myalgia, venous stasis, leg edema, arthritis, leg cramps, positional discomfort and habitual foot tapping were carefully investigated and excluded. Laboratory data, insulin use, family history and other related co-morbidities connected to RLS patients were recorded. RLS severity assessment was scored and recorded.

Results: 318 patients were included in the study. The prevalence of RLS in type-2 DM patients was found to be 28.3%. RLS prevalence in females was 33.3% and 20.6% in males. 39 patients (43.3%) had a family history of RLS. 43 patients with RLS had a co-morbidity link with RLS. Any co-morbidity linked to RLS was not seen in 47 patients. The prevalence rate of RLS in patients without co-morbidities was 17.1%. Mean duration of DM in patients with RLS was 15.6±6.7years while in DM patients without RLS was 13.7±6.3years. The relationship between RLS and the duration of diabetes was found to be statically significant. (p=0.025). 68 (75.6%) of patients diagnosed with RLS were treated with insulin. A statistical significance was found in the development of RLS and insulin usage (p=0.035).

Conclusions: This is the first study which shows the RLS prevalence and risk factors in Turkish type-2 diabetes mellitus patients. The results indicated that RLS is much more frequent in DM patients even after excluding polyneuropathy than in general Turkish population. The duration of diabetes and insulin use are related to RLS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pcd.2018.08.006DOI Listing

Publication Analysis

Top Keywords

rls
19
patients
16
rls patients
16
diabetes mellitus
12
patients rls
12
restless legs
8
legs syndrome
8
rls type-2
8
type-2 diabetes
8
mellitus patients
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!